Patients’ average length-of-stay at U.S. hospitals is increasing, jumping 19.2% across the country for patients this year compared to 2019 levels, according to a report released Tuesday by the American Hospital Association. The increase is even greater for patients who are being discharged to post-acute care providers — their average length of stay rose by nearly 24%.
The report showed that hospitals are having a difficult time discharging patients in a timely manner. This is often because there are no available spots for patients who need to be transferred to outpatient facilities, such as centers for skilled nursing or behavioral health.
“Without anywhere safe to discharge these patients, hospitals are left to care for these patients longer than is medically necessary, resulting in added expenses to the hospital and less beds available to meet patient demand, and creating patient bottlenecks,” said Bharath Krishnamurthy, AHA’s director of policy and health analytics. “Also, the data show that patients, on average, are now sicker and more complex to treat compared to pre-pandemic levels which requires some patients to stay in the hospital longer.”
To remedy the increased costs that hospitals are burdened with as a result of this issue, Medicare should establish a temporary per diem payment for cases in which a patient is ready to leave the hospital but is unable to be discharged appropriately, Krishnamurthy declared.
He pointed out that Medicare doesn’t pay hospitals based on the number of days a patient stays in the hospital, but rather pays a fixed amount for each patient based on their illness.
“For example, in an acute care hospital, Medicare pays a predetermined amount based on diagnosis-related groups,” Krishnamurthy said. “Therefore, hospitals bear the burden of added costs associated with the additional days that patients are waiting to be discharged to their next level of care. Given the current workforce challenges, these delays have increased dramatically.”
Under the temporary Medicare per diem payment model that Krishnamurthy has proposed, the hospital would need to demonstrate that they made multiple attempts to contact providers at the next level of care. It would also need to document the reason these providers are not able to admit the patient. This would then trigger a payment, which would “be determined based on per diem methodologies that already exist in the Medicare program,” Krishnamurthy said.
Hospitals are clamoring for these types of interventions from the federal government as providers across the country continue to face extreme financial pressure. Hospitals’ expenses are expected to rise by $135 billion this year, according to Kaufman Hall. The consulting firm also predicted that 68% of hospitals will end the year operating at a financial loss.
“Ensuring that hospitals remain financially stable for the near term means that targeted support is critically needed now to ease the dramatic financial pressures faced by hospitals as a result of these discharge delays,” Krishnamurthy said.
Centene Charitable Foundation and Superior HealthPlan — the payer’s subsidiary in Texas — announced Monday that it is investing $7.9 million for a new multipurpose community center in Uvalde, Texas.
The project is in partnership with Community Health Development, Inc. (CHDI), a federally qualified health center in the area. The community center will provide primary medical care, behavioral health care, youth development resources, college and job preparation services for students and retail space for local businesses. It will also have a tranquility garden honoring the 21 victims of the May 24 shooting at Robb Elementary School.
“I’m eager to see the positive impact this new facility can have on this area,” Mark Sanders, CEO of Superior HealthPlan, wrote in an email. “It offers more space for healthcare, opportunities for enhanced technology to better meet the physical and behavioral health needs of Uvalde County, and it will pave the way to better serve students, helping them grow and develop and eventually prepare for college or job training so they can be successful in the next chapter of their lives.”
Executives from Centene, Superior HealthPlan and CHDI held a groundbreaking ceremony for the center on Friday. CHDI is still raising funds for the facility, which will cost $20 million in total, the Uvalde Leader News reported. The building is expected to be completed in late 2024.
Working with federally qualified health centers like CHDI is important to improve health equity, Sanders said. CHDI was founded in 1983 and provides care to about 11,000 people in Uvalde, Real, Edwards and Zavala counties in Texas, according to the provider’s website. Nearly 85% of its patients are at or below 200% of the federal poverty line, almost 47% of its patients are uninsured and over 12% of its patients are covered by Medicaid and the Children’s Health Insurance Program.
“In our experience, these healthcare organizations have deep roots in their local communities, enabling them to bridge social, ethnic and economic gaps to deliver preventive care, dental services, access to mental health care and so much more,” Sanders said.
Centene, Superior HealthPlan and CHDI have been planning the community center since shortly after the shooting at the elementary school took place, according to Sarah London, CEO of St. Louis, Missouri-based Centene.
“Six days after the horrific tragedy at the Robb Elementary School, Centene and Superior met with CHDI and local leaders to understand how we could best support Uvalde in what will necessarily be a long-term recovery,” London said in a news release. “As that process continues, expanding the resources available to the entire community for physical, mental and emotional health is an important step forward.”
Photo: Michail_Petrov-96, Getty Images
Last week, Nuance added Kentucky-based Baptist Health and Pennsylvania-based Einstein Healthcare to its precision imaging network, a platform that allows healthcare providers to adopt AI-powered diagnostic imaging tools at the point of care.
Nuance, which was acquired by Microsoft last year, produces speech recognition and AI software for healthcare organizations.
Joining the network means that radiologists can deploy AI tools faster and more efficiently, according to Brett Oliver, Baptist’s chief medical information officer. He said the network will help radiologists adopt a broader range of algorithms, which means they will have an easier time figuring out which tools make the biggest impact on patient care.
To an outsider, the amount of time it takes for a health system to adopt a new AI tool might seem “ridiculous,” Oliver said in an interview. This is due to all the vetting that tools must undergo — hospitals must get legal contracts reviewed, ensure that the tool stores data securely, determine its compatibility with various interfaces, and so on.
“One of my colleagues will say, ‘Hey, I saw this product and I really think it can help me with 3D mapping out my brain surgeries. I just think it’s gonna make for better outcomes.’ Traditionally I would have to say ‘Okay, let’s go through the product, see some screenshots and maybe have somebody who’s used it before talk to us.’ It’s a six to nine month process, and it’s expensive,” he said.
More than 12,000 healthcare facilities have joined Nuance’s precision imaging network to speed up that process for physicians. The network is designed to give radiologists and other specialty physicians access to an ecosystem of third-party AI-powered diagnostic tools that they can embed right into their workflows — without having to build and maintain the infrastructure that is otherwise needed to adopt these products. The platform can be integrated into EHRs, Nuance’s PowerScribe reporting product and other clinical systems.
The network was launched about a year ago, and it is powered by the Microsoft Azure cloud platform.
“We’ve got a great relationship with Nuance, and we have PowerShare and PowerScribe already implemented and ready to go. There was very little technical setup to get to this point, and start our process with [the precision imaging network.] But it was really just the platform approach that sold me — we’ve got to be able to plug and play some of these algorithms more readily if we’re going to advance things quickly,” Oliver said.
Baptist is a nine-hospital health system with more than 1,500 providers and a network of more than 2,000 independent physicians. The health system is hoping that joining Nuance’s precision imaging network will improve the accuracy of the treatment it provides to patients, especially those with multiple sclerosis and dementia, Oliver said.
For example, AI imaging tools can look at scans sequentially at the point of care and determine the percentage for which plaque formation is either up or down. This can help neurologists treating dementia or MS make more informed decisions about switching patients’ medications.
It’s important that those types of tools be implemented more broadly in a quick manner, Oliver said adding that the faster the algorithms get implemented, the faster they can start improving clinical quality across the health system.
Photo: Darunechka, Getty Images
Labor shortages are a global problem, but they matter more in some sectors than in others. In retail, for example, not having enough staff is annoying and stressful; for public health and health care, it can mean lives lost or diminished.
Even before the pandemic, the British medical journal, Lancet, estimated that global health systems were 43 million people short. Now, burnt out by Covid-19, labor gaps threaten to grow to alarming proportions. In 2021, for example, 44 percent of US public-health workers said that they were considering leaving in the next five years. Given that demand for public health services is growing, the labor problem is unlikely to resolve itself.
Every public health system is unique, and the reasons for shortages vary. To respond, leaders can analyze their particular needs and then take action to develop and re-stock the talent pool. But how? Here are four actions that can help.
Support current workersPublic health embodies a noble mission: keeping people alive and well. But to do that, it’s important to promote the wellness and development of those who actually make that mission real. For a start, public-health organizations are known for being hierarchical and bureaucratic—to a fault. A flatter org chart could deliver greater responsiveness and fewer frustrated workers. In addition, employees in all sectors value a statement of expectations. That helps to explain why organizations that clearly set out post-pandemic work arrangements have seen a threefold increase in feelings of inclusionand an almost fivefold increase in feelings of individual productivity. Finally, individuals want to develop their careers—and many are not satisfied with existing options. Think about how to restructure career pathways to make them both clearer and more flexible. Offer ways for people to move laterally, so that they can explore different roles. Identify the needs of different subsegments—laboratory specialists, say, or nurses—and tailor retention initiatives to each type.
Hire and train for future capability needsPresent needs are urgent, but new competencies will be required. Agencies therefore may want to keep in mind how to hire and upskill employees in targeted capability areas to meet evolving public health priorities. For example, the global prevalence of anxiety and depression rose 25 percent in the first year of the pandemic. Public health systems could help fill this need by hiring professionals, creating training programs, and building partnerships with community organizations, academic institutions, and others.
There is also growing demand for data collection and analysis. The pandemic revealed that too many public-health systems didn’t have the information technology (IT) systems needed to capture the data they needed. From a more aspirational perspective, advanced analytics can reveal important insights, such as using syndromic surveillance techniques to spot outbreaks or analyzing environmental and social data to predict risks of lead poisoning or other dangers. This is not just a matter of hiring IT specialists, although that is essential. Public health decision makers—from policy makers to local partners—can also benefit from becoming data literate.
Plan for crisesCovid-19 is a reminder that the unexpected happens — that is why innovation, flexibility, and resilience are critical. One possible approach is to offer training to build up local reserves in less specialized roles who are on “warm standby,” meaning that they can be marshaled at a moment’s notice—as Japan did after the 2011 Tohoku earthquake. For highly specialized roles, national and international organizations could train staff centrally and then deploy them as needed. In terms of existing workers, the goal is to reassess policies to optimize productivity. In an emergency, for example, that could mean establishing emergency thresholds that trigger specific actions, such as temporarily suspending licensing restrictions to allow providers to practice across borders; authorizing pharmacists to prescribe critical medications; or simplifying license renewal processes to bring potential workers out of retirement.
Develop robust talent pipelinesProviders could think of it this way: If they were starting from scratch, how would they go about recruiting candidates? The answer will almost always be, not the way we do it now. The goal, then, is to build streamlined, user-friendly systems that maximize application completion and yield, including leveraging analytically backed digital labor platforms.
Partnerships can be used to great effect. For example, one ministry of immigration in a G-20 country established more than 15 partnerships to attract tech talent, which helped get approximately 100 candidates through its pipeline. Other promising approaches include simplifying job qualifications to emphasize capabilities rather than experience, centralizing public health job listings, ensuring reasonable application turnaround times, providing competitive compensation packages, and offering remote or hybrid work models.
Covid-19 was a terrible human tragedy, costing more than 6.5 million lives. The economic costs are incalculable, but start at $12.5 trillion. Many public-health professionals were little short of heroic, and the case for effective public-health systems was proved. If the lessons of the pandemic are not learned and acted on, however, that would be an additional—and avoidable—tragedy.
By taking these actions, local, national, and global systems could improve their societies for generations to come. That would be a worthy legacy of a terrible time.
According to a HealthSparq survey of 100 hospitals and health systems, 92% of providers want greater collaboration with health plans — believing this will lead to improved patient outcomes and reduced cost of care.
Although payers and providers share the same goal of providing the highest quality of patient care while lowering costs, historically, federal payment models under which providers have been reimbursed for their services haven’t been aligned with those for payers. Thus, this mismatch hasn’t been conducive to helping either side achieve this desired result.
To help both payers and provider organizations to succeed under this new value-based care model, we’ve outlined four strategies below that will help the two sides collaborate better on shared goals.
Strategy #1: Develop a data-sharing strategy.
Providers are primarily responsible for collecting clinical data, which is used to understand the patient’s health status and medical history. By contrast, payers work primarily with patient claims data, which is used for billing. Currently, many health plans share their data with provider groups but do so in their plan-specific formatting. This leaves provider organizations with the job of aggregating data across payers or working with disparate and disjointed data sets.
One method for sharing data more effectively and efficiently is for payers to fold in any of their data into a provider’s existing data-analytics engine. Payers who are willing to work within a provider organization’s data-analytics engine eliminate the administrative burden of aggregating data or working with multiple disparate lists.
Alternatively, a payer-agnostic interoperability solution with a bidirectional pipeline can be used, allowing both parties to upload and share data within a single system. More often than not, the information in a medical chart is more complete and accurate than what is on a claim. Because payers generally only have access to information on a claim, they often request records for risk adjustment chart reviews on an annual basis. Provider groups may be reluctant to accommodate en masse chart requests, but incorporating payer access to medical records via a bidirectional interoperability solution can reduce or eliminate health information management (HIM) teams’ administrative burden in sending charts.
Lastly, data strategy should not be built within a silo. Early on, payers and providers can form a working group of all stakeholders involved — from risk adjustment to quality teams — and create a shared data strategy. As the partnership continues, the group should be flexible, meeting regularly to measure how the strategy is performing and make improvements as needed.
Strategy #2: Create a long-term plan for taking on risk.
Before a provider group even decides to take on risk under a VBC model, payers can implement “triggers” that determine an organization’s readiness for downside risk. One example is a population trigger, which ensures that the size of the group’s population is large enough to sustain a risk-adjusted contract. This is important because if even one beneficiary is extremely high-risk in a very small risk-adjusted patient population, they may have a huge impact on its costs. Another type of trigger is a quality trigger that can demonstrate a provider organization’s ability to execute preventive services and manage chronic conditions, which are key to succeeding under a risk-based contract.
The provider organizations that pass these triggers shouldn’t be expected to take on risk overnight. Many lack experience and knowledge for taking on risk — especially those doing so for the first time. Payers can offer financial incentives for providers to start participating in alternative payment models by starting them off with an upside-only model. Under these contracts, providers only share in savings if they spend below a certain benchmark or budget; if they exceed it, they won’t have to reimburse the payers.
From there, providers can shift to a downside-risk arrangement, under which they still share in savings for meeting or going below costs but must pay reimbursements for exceeding costs. Through this gradual process, small provider groups taking on risk for the first time can be eased into operating under a shared-savings model. Most importantly, they’re given the time to build their own infrastructure needed to succeed independently from the payer.
Strategy #3: Invest in provider-friendly technologies and services.
In addition to creating financial incentives, payers and provider groups can also invest in technologies and services that enhance performance under risk-based contracts. For example, provider organizations can invest in a point-of-care tool, which administrative teams use to examine a patient’s entire medical history before the visit. The tool then gives the clinician a focused “snapshot” of relevant data points, such as suspected conditions that have never been diagnosed and prior year diagnoses that are undocumented. This reduces administrative burden and gives a clinician access to the data at a time when it can be immediately acted upon — when the patient is in the office.
In addition to investing in technologies that fuel concurrent strategies, payers can leverage those that improve retrospective work by outsourcing coding to vendors. By leveraging the power of machine learning and natural language processing (NLP), these vendors can code charts to validate coding at a very high level of accuracy. Furthermore, the right vendor can help with retrospective submission of coding results to the appropriate payers.
Strategy #4: Initiate shared member engagement programs.
To create an opportunity for providers to interact with the beneficiaries they cover directly, payers can partner with their local community’s provider organizations to coordinate events like World Diabetes Day or Annual Wellness Days. In turn, provider groups can also invite payer representatives and educators to sponsor and participate in their community outreach efforts. Through these events, payers and providers can meet face-to-face and maximize the resources available to patients.
Often, providers are unaware of extra benefits their Medicare Advantage patients have included for free in their plans. For example, payers and providers can collaborate on bringing awareness to benefits like transportation, meals after surgery, dental or vision coverage, and Silver Sneakers programs. By implementing these member engagement programs, payers and providers can work together to address social determinants of health (SDOH) issues by better understanding their community’s health needs and increasing access to care.
The future of the payer-provider relationship
Given that providers are under increased pressure from CMS to take on some form of downside risk by 2025, they and health plans can utilize these four strategies to make the transition smoother. And as their payment systems become more aligned, both parties will be able to understand each other better and improve coordination of care.
Photo: PeopleImages, Getty Images
he COVID-19 pandemic affected people of all ages and from different walks of life, but just how much did it impact adolescents? In a new study, a team of researchers found that it may have physically altered teens’ brains.For their study, published Thursday in Biological Psychiatry: Global Open Science, the researchers compared the brains of teens before the pandemic (pre-COVID) and after experiencing the pandemic-related shutdowns (peri-COVID).The researchers weren’t initially aiming to make the comparison, according to the news release from Stanford University. Before the pandemic, the researchers were conducting a longitudinal study on the effects of early life stress on adolescents in the San Francisco Bay Area, wherein they were invited for assessments every two years.However, the study — just like most things across the world — came to a halt when the pandemic hit. As such, the researchers then had to have a “hard restart,” study first author, Ian Gotlib of Stanford University, said as per the news release.
This, however, gave them a unique opportunity to look at the impacts of the pandemic on adolescents’ brains.”(I)t is not clear whether youth who lived through the pandemic and its shutdowns are comparable psychobiologically to their age- and sex-matched peers assessed before the pandemic,” the researchers wrote.To find out, the researchers compared the peri- and pre-COVID participants, matching them “as closely as possible” in terms of age and sex.Indeed, they found that the pandemic appeared to have physically altered the adolescents’ brains. Those who experienced the pandemic shutdowns had “reduced cortical thickness, larger hippocampal and amygdala volume, and more advanced brain age.”Their internalizing of mental health problems was also more severe.Although it’s quite natural for people’s brains to change as they age, the results of the scans show that the process appears to have “sped up” in the teens they scanned after the shutdowns. The features in those teens’ brains, researchers say, “are more typical of individuals who are older or who experienced significant adversity in childhood.”According to the researchers, this shows that the pandemic not only affected these young people’s mental health but also affected their brain maturation, with the features indicating “older-appearing brains.”This, they say, is something that researchers conducting longitudinal studies halted by the pandemic may want to take note of.The question now is whether the changes are permanent or merely temporary, Gotlib said, noting that there’s also the question of whether their chronological age will “eventually catch up to their ‘brain age,'” and how this may affect them in the long run.”(I)t is important that we continue to follow and assess individuals who were recruited and assessed prior to the pandemic; this type of research offers the strongest possibility for us to examine the effects of a major stressor experienced on a global scale,” the researchers wrote.
Verve Therapeutics now has the formal FDA documentation specifying what the regulator wants to see before it allows the company to begin human testing of its gene-editing therapy for an inherited form of high cholesterol.
VERVE-101 is designed to turn off PCSK9, a gene that produces a liver protein that makes it more difficult for the body to clear low-density lipoprotein, the “bad” form of cholesterol. Patients have already been dosed in a clinical program underway in New Zealand and the U.K. Last month, the FDA placed a clinical hold on the Boston-based company’s new drug application for a U.S. trial.
The FDA wants to see more preclinical data regarding potency differences between human and non-human cells as well as additional data about the risks that the changes made by the therapy can be inherited by a patient’s children, Verve said in a Monday regulatory filing. The FDA asked that Verve modify the clinical trial protocol in the U.S. to incorporate additional contraceptive measures and to increase the length of time between the dosing of patients.
The FDA also has concerns about off-target effects. The filing states the agency asked the company to provide analyses of data showing whether the therapy’s effects reach cell types beyond liver cells. Furthermore, the FDA has asked to see the available data from New Zealand and U.K. so far. Those data were not part of the initial submission filed with the FDA. Verve said enrollment is continuing in those regions and the company plans to report initial safety and pharmacodynamic data from the dose-escalation part of the trial in the second half of 2023. Without specifying a timeline, the company said it plans to submit a response to the FDA’s information requests “as expeditiously as possible.”
The lifting of a clinical hold on another experimental genetic medicine was among the other recent regulatory news from the past week, which included two drug approvals and one rejection. Here’s a roundup of those developments:
—The FDA lifted a clinical hold on the investigational new drug application for a Beam Therapeutics gene-edited cell therapy for acute lymphoblastic leukemia. The FDA placed the hold on the program, BEAM-201, in August. With the hold lifted, the Cambridge, Massachusetts-based biotech is now cleared to proceed with tests in humans. BEAM-201 is an off-the-shelf cell therapy that employs four edits made with base-editing technology. Beam said it will provide details for the program’s next steps in 2023.
—The FDA has approved the first fecal microbiota treatment for preventing the recurrence of Clostridioides difficile (C. diff) infection in adults. The regulatory decision covers those who have finished a course of antibiotics for the potentially deadly infection. The Ferring Pharmaceuticals product, named Rebyota, is made from stool provided by qualified donors. This rectally administered live biotherapeutic is intended to restore the gut microbiome, which in turn prevents episodes of C. diff infection.
—A Rigel Pharmaceuticals drug won FDA approval for treating acute myeloid leukemia (AML) with a particular genetic signature. The South San Francisco-based biotech will commercialize the drug, olutasidenib, under the name Rezlidhia. The small molecule is designed to target mutated isocitrate dehydrogenase-1 (IDH1), an enzyme found in cancerous cells. Blocking this enzyme is intended to restore normal differentiation of myeloid cells. The regulatory decision for Rezlidhia covers the treatment of adults whose AML has the IDH1 mutation as detected by an FDA-approved test.
—The FDA turned down Y-mAbs Therapeutics application seeking approval for its drug to treat a rare pediatric brain cancer. The drug, omburtamab, was developed to address leptomeningeal metastases, which is the spread of neuroblastoma from the brain to the membranes surrounding the brain and spinal cord. The negative regulatory decision came a little more than a month after an independent advisory committee to the FDA voted unanimously that New York-based Y-mAbs had not provided enough evidence to show that the clinical program, which compared omburtamab to a historical control group, improved overall survival in patients.
—Eli Lilly’s Covid-19 drug bebtelovimab is no longer authorized for use anywhere in the U.S. According to the FDA, the change was made because the antibody is not expected to work against the omicron subvariants BQ.1 and BQ.1.1., which together account for 57% of all cases nationally. Revocation of the Lilly drug’s emergency use authorization removes from the market the last remaining monoclonal antibody drug for Covid-19.
Photo: Sarah Silbiger, Getty Images
About two weeks ago, California Nurses Association reached a tentative agreement with Kaiser Permanente, averting what would have been the biggest private sector nurses strike in American history. On Monday, the union announced that its nurses voted to ratify a new four-year contract — one that includes provisions for a significant wage increase, improved staffing and more.
California Nurses Association represents about 22,000 nurses at 22 Kaiser facilities.
The averted strike would have involved about 21,000 nurses and nurse practitioners at 21 Kaiser Permanente facilities in Northern California. These nurses had been in negotiations since June. The strike would have also involved about 1,000 nurses at Kaiser’s medical center in Los Angeles. They joined their Northern California nurse colleagues in September.
The new contract’s provisions to retain experienced nurses and hire new ones is expected to provide much-needed relief for nurses amid staffing shortages, according to Cathy Kennedy, who is the president of the California Nurses Association and a nurse in the neonatal intensive care unit at Kaiser’s medical center in Roseville.
“We are so happy that this contract adds more than 2,000 positions across our Northern California facilities,” she said in a statement sent to MedCity News. “That is amazing and will improve staffing greatly.”
In an interview last month, Kennedy called the contract a “huge win” for Kaiser’s nurses.
Under the contract, Kaiser is increasing wages for its Northern California nurses by 22.5% over four years. This wage growth “is driven by the changing economy, including inflation, significant changes in the marketplace and our commitment to providing our employees with excellent pay and benefits to attract and retain the best nurses,” according to the health system.
Kaiser also agreed to increase tuition reimbursement for nurses’ continuing education, maintain a three-month stockpile of personal protective equipment, and scale workplace violence prevention plans to all facilities.
The contract’s patient-first language and provisions for equity are significant as well.
The ratified contract asserts that healthcare is a human right, Kennedy pointed out. It also states that the U.S. healthcare system must eliminate racial and ethnic disparities in patient outcomes, promote culturally competent care delivery, and expand the diversity of its workforce.
Kaiser has promised to create a new regional committee for equity, diversity and inclusion at each facility. These committees will be composed of two nurses from each facility, and they will “bring nurses to the table” to address systematic racism within the healthcare system, Kennedy explained.
When the new contract was put on the table last week, Kaiser said it was “proud of the work our nurses do and we are making sure Kaiser Permanente continues to be the best place to work for our valued nurses.”
Nurses at Kaiser’s Los Angeles medical center ratified a new contract on November 22. For the Northern California nurses, voting began on November 22 and concluded on December 2.
The contract’s ratification comes about six weeks after another swath of Kaiser’s Northern California employees approved a four-year contract of their own — that time, it was about 1,600 mental health workers. Their approval followed a 10-week strike.
Picture: rvolkan, Getty Images
As the world enters a possible recession and healthcare costs rise, affordability will be a key concern for employers in 2023, according to the Business Group on Health. Other top health trends for employers next year will be continued support of wellbeing programs and health equity.
“None of these are new issues, but they’re magnified and a bit nuanced in light of current events and where the macroeconomic environment is,” Ellen Kelsay, president and CEO of Business Group on Health, said in an interview. “That’s why we’ve really pulled them forward as things that we’re keeping a sharp eye on as we head into 2023.”
The Business Group on Health is a nonprofit organization that represents large employers on health and benefits policy.
Here are the top three trends the organization is watching for employers in 2023:
Healthcare costs
Employers will likely see higher healthcare costs in 2023, partially due to an increase in demand for care after people put off services during the beginning of the pandemic. A recent Business Group on Health survey of 135 large employers found that 43% have already seen a rise in medical services because of delayed care from Covid-19, and another 39% expect to in the future.
Additionally, cancer is now the top condition driving healthcare costs, surpassing musculoskeletal conditions, another Business Group on Health Survey found. This is because cancers are now being identified at later stages.
“During the pandemic, there were a lot of preventive visits and cancer screenings that didn’t occur,” Kelsay said. “So there’s a backlog of services that now people are going to get treated for and we might see some more late stage cancers being diagnosed, which are going to be more expensive and challenging to treat.”
In response, many employers are absorbing the increases in healthcare costs, rather than putting the burden on employees, Kelsay said. They’re also moving away from fee-for-service payment models to more value-based arrangements, and looking at their vendors to see if they have any duplication of services.
More focus on health and wellbeing programs
Despite this increase in healthcare costs, the Business Group on Health doesn’t anticipate health and wellbeing programs going away for employees, Kelsay said. In fact, 65% view health and wellbeing as an integral role in their workforce strategy, up from 27% five years ago, the nonprofit found.
“We’ve had some folks say, ‘Well, gosh, maybe in a time of uncertain economic situations, employers might start to retract some of those efforts,’” Kelsay said. “We don’t see that happening at all. In fact, for a number of years when we’ve surveyed our employer members, they take a long-term view of their health and wellbeing offerings and really view them as … part of a strategic component of their overall workforce strategy.”
To continue offering these wellbeing programs, employers will be searching for partnerships that can provide high quality solutions and improve patient outcomes, Kelsay said. Many employers are focusing on programs for mental health, financial wellbeing and caregiver support, she added.
Efforts to battle health inequities
There are several key areas employers are looking to reduce health inequities within their organization, though it depends on the company. These areas include housing, food, maternal health, transgender care and care for neurodiverse populations, Kelsay said. Some employers are also looking to help workers living in rural communities.
“Different employers and different workforces might have different areas of inequity that they might be addressing,” Kelsay said. “But they’re very keen to make sure that all of their employees of any type of population or however they might identify have equal access to health and wellbeing services to treat their particular needs.”
Getty images, utah778
Health information exchanges (HIEs) ensure the secure mobilization of electronic health information across organizations within a region. Each state in the country has an HIE, and some even have more than one.
HIEs, which can be public or private, are meant to enable more effective care that better meets patients’ unique needs. They have been around for a couple decades, but results are mixed when it comes to their success. The next generation of HIEs must think beyond the transfer of information and explore how they can use real-time health data to improve population health outcomes, according to Jamie Bland, the president and CEO of CyncHealth.
CyncHealth is Nebraska’s designated statewide HIE and prescription monitoring program. The nonprofit became a statewide HIE in 2012, Bland said in an interview.
“If you think about how people access healthcare, as well as the differences in electronic health records and how they have evolved over the past 20 years, what we’re really trying to do is connect data to the person,” she declared.
With CyncHealth, a person’s health information follows them throughout their healthcare journey. When it’s appropriate for a provider to seek their information (perhaps for treatment or a check-in), their data is available as a health history. CyncHealth also provides citizens with their longitudinal health information, according to Bland.
“Having data follow the person is important for patient safety outcomes, care coordination and just really looking at population health overall,” she said.
A key way that CyncHealth is seeking to improve population health outcomes is through a program it launched six months ago in Omaha to improve health and equity in maternal and postpartum care. Under the program, CyncHealth coordinates a secure data exchange amongst key healthcare stakeholders such as Medicaid, hospitals, clinics, federally qualified health centers, primary care providers, OB-GYNs and substance use disorder clinics.
The program is designed to identify mothers and infants who are in need of care. The pilot identifies high-risk patients based on a wide variety of factors — including race, ethnicity, ZIP code and medical history — and it contacts providers so they can design a holistic care plan for their high-risk patients.
CyncHealth’s program for maternal and postpartum care also keeps providers informed about their patients’ real-time health data. For instance, let’s say a pregnant woman goes to the emergency department because she feels dizzy and is then diagnosed with high blood pressure. CyncHealth would notify all her treating providers to ensure they perform appropriate follow-up care. Interventions like these are important, as hypertension is a huge factor that contributes to maternal morbidity.
“This is a newer program, so we don’t have longitudinal data just yet. But what we hope to see in the data is that [adverse] outcomes — whether they be postpartum complications, or issues that could lead to death like in a pulmonary embolism or hemorrhaging after childbirth — can can be followed up on more rapidly than without this type of information exchange,” Bland said.
CyncHealth plans to keep this program running in the future, according to Bland. To measure its impact, she said the nonprofit will track how many notifications it sends to providers and how many were acted upon. CyncHealth will also look at how maternal mortality and morbidity data changes over time in Omaha.
This summer, HHS recognized CyncHealth’s Omaha program as one of the top 25 winners of Phase I of its health equity-focused postpartum care challenge.
“That recognition is really just underscoring the work that we’ve done to build a broad health information network,” Bland said. “When you have that foundation, you can really start to improve population health because it takes a data exchange to be able to react more quickly to information.”
Photo: FatCamera, Getty Images